Blum Robert I's Form 4 filing
Cytokinetics Inc (CYTK) · filed Nov 4, 2022
- Accession no.
- 0001127602-22-024962
- Filed
- Nov 4, 2022
- Trade date
- Nov 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $421.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blum Robert ICIK 0001288859 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2022 | Common Stock | MOption exerciseAcquired | +9,208 | $7.96 | +$73,295.68 | 415,297 | Direct | |
| Nov 2, 2022 | Common Stock | SSaleDisposed | −9,208 | $42.17 | −$388,301.36 | 406,089 | Direct | |
| Nov 2, 2022 | Common Stock | MOption exerciseAcquired | +792 | $9.65 | +$7,642.8 | 406,881 | Direct | |
| Nov 2, 2022 | Common Stock | SSaleDisposed | −792 | $42.17 | −$33,398.64 | 406,089 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2022 | Common Stock | MOption exerciseDisposed | −9,208 | $0.00 | $0 | 0 | Direct | |
| Nov 2, 2022 | Common Stock | MOption exerciseDisposed | −792 | $0.00 | $0 | 185,691 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.